Cardiovascular disease biomarkers derived from circulating cell-free DNA methylation

Area of Science:

• Cardiology
• Genomics
• Biomarker Discovery

Background:

• Acute coronary syndrome (ACS) is a leading cause of global mortality.
• ACS involves reduced or blocked blood flow to the heart, leading to tissue damage.
• Current ACS diagnosis relies on clinical findings, ECG, and plasma biomarkers.

Purpose of the Study:

• To investigate circulating cell-free DNA (ccfDNA) methylation profiles as novel biomarkers for ACS.
• To differentiate between the main types of ACS using ccfDNA methylation.
• To develop computational tools for applying these methods to other diseases.

Main Methods:

• Utilized cell type specificity of DNA methylation to deconvolute ccfDNA origins.
• Identified and validated methylation-based biomarkers for ACS stratification.
• Analyzed ccfDNA methylation profiles in patient cohorts.

Main Results:

• Identified hundreds of methylation markers associated with different ACS types.
• Validated these markers in an independent cohort.
• Found many markers linked to cardiovascular and inflammatory genes.

Conclusions:

• ccfDNA methylation serves as a promising non-invasive diagnostic tool for acute coronary events.
• The developed computational methods can be applied to chronic cardiovascular diseases.
• This approach offers a new avenue for cardiovascular disease diagnostics and research.